Tag - PFSCF

Developments

Liminal BioSciences presents new preclinical data at ASN Kidney Week

Liminal BioSciences (TSX:LMNL; OTCQX:PFSCF) and its collaborators presented new preclinical findings on a novel therapeutic approach to the treatment of inflammatory and fibrosis-related kidney diseases at the American...

November 11, 2019

Developments

Liminal BioSciences to sell bioseparations division to KKR

Liminal BioSciences (TSX:LMNL; OTCQX:PFSCF) signed a binding share purchase agreement for the proposed saleof its Isle of Man-based bioseparations business operated through subsidiary Prometic Bioseparations (PBL) to...

November 4, 2019

Developments

Liminal BioSciences to present PAH data at AHA meeting

Liminal BioSciences (TSX:LMNL; OTCQX:PFSCF) plans to present two scientific posters with new preclinical development in the treatment of pulmonary arterial hypertension (PAH) at the American Heart Association annual...

October 29, 2019

Tag - PFSCF

Liminal BioSciences presents new preclinical data at ASN Kidney Week

Liminal BioSciences to sell bioseparations division to KKR

Liminal BioSciences to present PAH data at AHA meeting

General

More